€84.0M
The round was led by Kurma Growth Opportunities Fund, Angelini Ventures, Wellington Partners, and Neva SGR.
N
Nuclidium
Nuclidium builds copper-based radiopharmaceuticals for precision cancer diagnosis and treatment.
Switzerland—Founded 2017
€84.0MTotal raised
Nuclidium is a Swiss clinical-stage biotech company developing copper-based radiopharmaceuticals for cancer diagnosis and treatment.
Founders
LJ
Leila Jaafar
Gv
Gustav von Schulthess